Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2

Human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known as SARS-CoV-2), lead global epidemics with high morbidity and mortality. However, there are currently no effective drugs targeting 2019-nCoV/SARS-CoV-2. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yadi, Hou, Yuan, Shen, Jiayu, Huang, Yin, Martin, William, Cheng, Feixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/
https://www.ncbi.nlm.nih.gov/pubmed/32194980
http://dx.doi.org/10.1038/s41421-020-0153-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073332/
https://www.ncbi.nlm.nih.gov/pubmed/32194980
http://dx.doi.org/10.1038/s41421-020-0153-3

Ejemplares similares